Related Experiment Video
Updated: Mar 28, 2026

A Rapid In Vivo Bioassay for Developmentally Active Enhancers
Identification of RNF168 as a PML nuclear body regulator
Kathy Shire1, Andrew I Wong1, Michael H Tatham2
1Department of Molecular Genetics, University of Toronto, 1 Kings College Circle, Toronto, Ontario, Canada M5S 1A8.
Abstract:
Promyelocytic leukemia (PML) protein forms the basis of PML nuclear bodies (PML NBs), which control many important processes. We have screened an shRNA library targeting ubiquitin pathway proteins for effects on PML NBs, and identified RNF8 and RNF168 DNA-damage response proteins as negative regulators of PML NBs. Additional studies confirmed that depletion of either RNF8 or RNF168 increased the levels of PML NBs and proteins, whereas overexpression induced loss of PML NBs. RNF168 partially localized to PML NBs through its UMI/MIU1 ubiquitin-interacting region and associated with NBs formed by any PML isoform. The association of RNF168 with PML NBs resulted in increased ubiquitylation and SUMO2 modification of PML. In addition, RNF168 was found to associate with proteins modified by SUMO2 and/or SUMO3 in a manner dependent on its ubiquitin-binding sequences, suggesting that hybrid SUMO-ubiquitin chains can be bound. In vitro assays confirmed that RNF168, preferentially, binds hybrid SUMO2-K63 ubiquitin chains compared with K63-ubiquitin chains or individual SUMO2. Our study identified previously unrecognized roles for RNF8 and RNF168 in the regulation of PML, and a so far unknown preference of RNF168 for hybrid SUMO-ubiquitin chains.
Insights
RNF8 and RNF168 proteins regulate Promyelocytic Leukemia nuclear bodies (PML NBs). Depleting these proteins increases PML NBs, while overexpressing them decreases PML NBs, revealing novel regulatory roles.
Area of Science:
- Cell Biology
- Molecular Biology
- Ubiquitination and SUMOylation Pathways
Background:
- Promyelocytic leukemia (PML) protein is crucial for PML nuclear bodies (PML NBs), which regulate vital cellular processes.
- The precise regulation of PML NB formation and stability is essential for cellular function.
Purpose of the Study:
- To identify novel regulators of PML nuclear bodies (PML NBs) within the ubiquitin pathway.
- To investigate the roles of RNF8 and RNF168 in the modulation of PML NB levels and protein modifications.
Main Methods:
- Screening of an shRNA library targeting ubiquitin pathway proteins.
- Analysis of PML NB levels and protein modifications upon RNF8 and RNF168 depletion or overexpression.
- Biochemical assays to determine the binding preference of RNF168 for modified ubiquitin chains.
Main Results:
- RNF8 and RNF168 were identified as negative regulators of PML NBs.
- Depletion of RNF8 or RNF168 led to increased PML NB levels and protein content.
- RNF168 binds to PML NBs and promotes PML ubiquitylation and SUMO2 modification.
- RNF168 preferentially binds to hybrid SUMO2-ubiquitin chains.
Conclusions:
- RNF8 and RNF168 play significant, previously unrecognized roles in regulating PML NBs.
- RNF168 exhibits a novel preference for binding hybrid SUMO-ubiquitin chains, impacting PML modification.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Negative Regulator Molecules
Master Transcription Regulators
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Transcriptional Regulation: Riboswitches
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

